Improving Cardiovascular Treatment Approaches Among Minorities

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00101478
First received: January 10, 2005
Last updated: April 10, 2009
Last verified: April 2009
  Purpose

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.


Condition
Cardiovascular Diseases
Heart Diseases
Diabetes Mellitus
Hypertension

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Estimated Enrollment: 800
Study Start Date: September 2004
Estimated Study Completion Date: August 2009
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

The study groups will be selected from primary and family health clinics, community, and patients of physicians participating in the study.

Criteria

Inclusion Criteria:

  • Uncontrolled hypertension or diabetes

Exclusion Criteria:

  • Medical condition that would prevent treatment for hypertension at the University of Maryland
  • Medical condition that would prevent treatment for diabetes at Bon Secours
  • Uninsured
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00101478

Locations
United States, Maryland
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
Bon Secours Hospital
Baltimore, Maryland, United States, 21223
Sponsors and Collaborators
Investigators
Principal Investigator: Elijah Saunders, MD University of Maryland, Baltimore County
Principal Investigator: Reed Winston, MD Bon Secours Hospital Baltimore
Principal Investigator: Fadia T. Shaya, PhD, MPH Universitiy of Maryland Baltimore
Principal Investigator: Wallace R. Johnson, MD Bon Secours Hospital Baltimore
  More Information

No publications provided

Responsible Party: Elijah Saunders, MD, University of Maryland School of Medicine
ClinicalTrials.gov Identifier: NCT00101478     History of Changes
Other Study ID Numbers: 1283, U01 HL79151
Study First Received: January 10, 2005
Last Updated: April 10, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Hypertension
Diabetes Mellitus
Vascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on October 02, 2014